Official Resources
- Homepage: https://www.schrodinger.com/platform/products/desmond/
- Documentation: https://www.schrodinger.com/documentation
- License: Commercial (Schrödinger)
Overview
Desmond is a high-performance molecular dynamics engine developed by D.E. Shaw Research and distributed by Schrödinger. It is known for exceptional GPU performance and is widely used in pharmaceutical industry for drug discovery simulations.
Scientific domain: Biomolecular simulations, drug discovery, GPU-accelerated MD
Target user community: Pharmaceutical researchers, computational drug discovery
Theoretical Methods
- Classical molecular dynamics
- OPLS force fields (OPLS3e, OPLS4)
- Free energy perturbation (FEP+)
- Replica exchange
- Metadynamics
Capabilities (CRITICAL)
- Ultra-fast GPU MD simulations
- FEP+ for binding affinity prediction
- Maestro GUI integration
- Automated system setup
- Enhanced sampling methods
- Membrane protein simulations
Key Strengths
Performance:
- Industry-leading GPU speed
- Optimized for NVIDIA GPUs
- Microsecond timescales routine
Drug Discovery:
- FEP+ for lead optimization
- Automated workflows
- Validated force fields
Inputs & Outputs
- Input formats: Maestro structures, PDB
- Output data types: Trajectories, FEP results
Advanced Features
- FEP+: Free energy perturbation
- WaterMap: Hydration site analysis
- Metadynamics: Enhanced sampling
- Membrane builder: Automated setup
Performance Characteristics
- Exceptional GPU performance
- Optimized for drug discovery
- Large system support
Computational Cost
- Commercial license required
- GPU provides major speedup
- Overall: Industry-leading performance
Best Practices
- Use FEP+ for lead optimization
- Validate with experimental binding data
- Use Maestro for system preparation
- Enable GPU acceleration
- Use appropriate OPLS force field version
Limitations & Known Constraints
- Commercial license (expensive)
- Schrödinger ecosystem lock-in
- Less flexible than open-source
- Requires Maestro interface
- Limited customization compared to open-source
Application Areas
- Drug discovery
- Lead optimization
- Binding affinity prediction
- Protein-ligand simulations
- GPCR and membrane protein studies
Comparison with Other Codes
- vs GROMACS: Desmond commercial with FEP+, GROMACS open-source
- vs AMBER: Both strong for biomolecules, Desmond better FEP workflow
- vs ACEMD: Both GPU-focused, Desmond in Schrödinger ecosystem
- vs OpenMM: Desmond turnkey solution, OpenMM more flexible
- Unique strength: FEP+ for drug discovery, Maestro integration, validated OPLS force fields
Community and Support
- Commercial support (Schrödinger)
- Extensive documentation
- Training courses
- User forums
- Regular updates
Verification & Sources
Primary sources:
- Website: https://www.schrodinger.com/platform/products/desmond/
- K.J. Bowers et al., SC '06 Proceedings (2006)
- W.L. Jorgensen et al., J. Chem. Theory Comput. (OPLS papers)
Secondary sources:
- Schrödinger documentation
- FEP+ validation studies
- Published pharmaceutical applications
Confidence: VERIFIED
Verification status: ✅ VERIFIED
- Commercial software (Schrödinger)
- Industry standard for drug discovery
- Extensive pharmaceutical validation
- Active development and support